Yogen Saunthararajah
Professor, Department of Medicine, School of Medicine · Case Western Reserve University
Credentials: · · ·
History
- 1999–2000
- 1996–1999
Hematology and Medical Oncology
- 1993–1996
University of Hawaii Queens Medical Center
University
Research
JAMA · 2003 · 690 citations
Dynamics of clonal evolution in myelodysplastic syndromes
Nature Genetics · 2017 · 363 citations
Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms
Cancer Cell · 2015 · 353 citations
43 papers · 1 as a fellow
32 papers
- RT
18 papers
15 papers
15 papers
11 papers
10 papers
9 papers
Grants
- 2021–2025
PET Imaging of Viral Infection
National Institute of Allergy and Infectious Diseases · R21
PI · $442.8K · Case Western Reserve University
- 2019–2025
Targeting Enzymatic Regulation of Fetal Hemoglobin Repression
National Heart, Lung, and Blood Institute · P01
Project lead · $5.1M · University of Michigan at Ann Arbor
- 2022–2025
Operationalizing DNMT1-Targeting to Treat Chemorefractory Pancreatic Cancer
National Cancer Institute · R21
Contact PI · $409.5K · Cleveland Clinic Lerner Com-Cwru
- 2016–2024
Imaging Liver Cancer Proliferation
National Cancer Institute · R01
PI · $1.8M · Case Western Reserve University
Clinical trials
- 2012–2018
Study of Decitabine and Tetrahydrouridine (THU) in Patients With Sickle Cell Disease
Principal investigator · Completed · Phase 1
Yogen Saunthararajah
- 2010–2012
Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome
Principal investigator · Completed · Phase 1, Phase 2
Case Comprehensive Cancer Center
- 2009–2017
Principal investigator · Completed · Phase 2
Case Comprehensive Cancer Center